Occurrence of ventilator associated pneumonia using a tracheostomy tube with subglottic secretion drainage.


Journal

Minerva anestesiologica
ISSN: 1827-1596
Titre abrégé: Minerva Anestesiol
Pays: Italy
ID NLM: 0375272

Informations de publication

Date de publication:
08 2020
Historique:
pubmed: 26 5 2020
medline: 1 9 2021
entrez: 26 5 2020
Statut: ppublish

Résumé

Ventilator-associated pneumonia (VAP) is a significant cause of morbidity and mortality in critically ill patients who require mechanical ventilation (MV). Subglottic secretions above the endotracheal cuff are associated with bacteria colonization of lower respiratory tract, causing VAP. A preventive strategy to avoid subglottic secretion progression is the drainage with special tracheal tubes effective in preventing both early onset and late onset VAP. The purpose of this study was to measure VAP incidence in tracheostomized patients with suction above the cuff. The authors performed a matched cohort study with historical control in three academic Intensive Care Units (ICUs): upon ICU admission, patients requiring MV were submitted to tracheostomy with a tracheal tube allowing drainage of subglottic secretions (treatment group). A control group without suctioning above the cuff was selected applying the propensity score matching on dataset of previous ELT Study. VAP occurrence at 28-days from intubation was the primary endpoint; hospital mortality and ICU-free days at 28-days were the secondary endpoints. Between July 2014 and April 2016, 125 tracheostomized patients were included in the analysis. 232 tracheostomized patients without suctioning were selected as a control group for the matched cohort study. The application of propensity score matching selected 60 patients to compare the two groups. Incidence of VAP was 8% in treatment group and 19.4% in the control group (P value =0.004). After balance with propensity score matching VAP was 8.3% and 21.7% (P value =0.0408), respectively. Subglottic secretion drainage reduces incidence of VAP in critically ill patients requiring ongoing MV via tracheostomy.

Sections du résumé

BACKGROUND
Ventilator-associated pneumonia (VAP) is a significant cause of morbidity and mortality in critically ill patients who require mechanical ventilation (MV). Subglottic secretions above the endotracheal cuff are associated with bacteria colonization of lower respiratory tract, causing VAP. A preventive strategy to avoid subglottic secretion progression is the drainage with special tracheal tubes effective in preventing both early onset and late onset VAP. The purpose of this study was to measure VAP incidence in tracheostomized patients with suction above the cuff.
METHODS
The authors performed a matched cohort study with historical control in three academic Intensive Care Units (ICUs): upon ICU admission, patients requiring MV were submitted to tracheostomy with a tracheal tube allowing drainage of subglottic secretions (treatment group). A control group without suctioning above the cuff was selected applying the propensity score matching on dataset of previous ELT Study. VAP occurrence at 28-days from intubation was the primary endpoint; hospital mortality and ICU-free days at 28-days were the secondary endpoints.
RESULTS
Between July 2014 and April 2016, 125 tracheostomized patients were included in the analysis. 232 tracheostomized patients without suctioning were selected as a control group for the matched cohort study. The application of propensity score matching selected 60 patients to compare the two groups. Incidence of VAP was 8% in treatment group and 19.4% in the control group (P value =0.004). After balance with propensity score matching VAP was 8.3% and 21.7% (P value =0.0408), respectively.
CONCLUSIONS
Subglottic secretion drainage reduces incidence of VAP in critically ill patients requiring ongoing MV via tracheostomy.

Identifiants

pubmed: 32449334
pii: S0375-9393.20.13989-0
doi: 10.23736/S0375-9393.20.13989-0
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

844-852

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Auteurs

Pierpaolo Terragni (P)

Department of Anesthesiology and Intensive Care Medicine, University of Sassari, Sassari, Italy - pterragni@uniss.it.

Rosario Urbino (R)

Unit of Anesthesia and General Intensive Care, Molinette Hospital, Città della Salute e della Scienza, Turin, Italy.

Franco Mulas (F)

Unit of Anesthesia and General Intensive Care, University Hospital of Sassari, Sassari, Italy.

Laura Pistidda (L)

Unit of Anesthesia and General Intensive Care, University Hospital of Sassari, Sassari, Italy.

Andrea P Cossu (AP)

Unit of Anesthesia and General Intensive Care, University Hospital of Sassari, Sassari, Italy.

Davide Piredda (D)

Unit of Anesthesia and General Intensive Care, University Hospital of Sassari, Sassari, Italy.

Chiara Faggiano (C)

Unit of Anesthesia and General Intensive Care, Hospital of Chivasso, Chivasso, Turin, Italy.

Davide Falco (D)

University of Sassari, Sassari, Italy.

Giuseppina Magni (G)

Umberto I Polyclinic Hospital, Sapienza University, Rome, Italy.

Luciana Mascia (L)

Department of Anesthesiology and Intensive Care Medicine, Sapienza University, Rome, Italy.

Claudia Filippini (C)

University of Turin, Turin, Italy.

Vito Marco Ranieri (VM)

Department of Anesthesia and Intensive Care Medicine, Sant'Orsola Polyclinic, Alma Mater Studiorum University of Bologna, Bologna, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH